Hopefully you have read the recent press release published on the website of our sister company CROS NT (a PM Holding company) which was acquired by Alira Health, a leading international healthcare, and life sciences advisory services company.
CROS NT will leave PM Holding and become part of Alira Health’s complete end-to-end offering, with PM Holding investing in Alira Health as a minority shareholder. seQure will continue under PM Holding and will strengthen its focus on lean and optimised approach to Quality Assurance and Pharmacovigilance.
As the Life Sciences industry has changed irreversibly in 2020, there is much more focus on further enhancement of technology with buy in both from sponsors, providers and patients.
Our ambitious goal is to unite technology and Quality Assurance and Pharmacovigilance and leverage the power of technology both to deliver our services even more efficiently and increase compliance for our clients.
As I look ahead, the future is bright – right now, we are working tirelessly to expand our operational team and further strengthen it with additional innovation experts.
This is a year of growth, change and transition. At the beginning of 2021, we said that there is #nogoingback and we stand by this. We will continue to support the transformation of our industry to ensure that patients are offered reliable and safe clinical trials regardless of challenges.
Paolo Morelli, CEO of PM Holding (seQure & Arithmos) and Executive Vice President, Biometrics of Alira Health